Size of thermosensitive liposomes influences content release

Journal of Controlled Release

Volumn 147, Issue 3, 2010, Pages 436-443

  Hossann, Martin ^a,b,c   Wang, Tungte ^a,b   Wiggenhorn, Michael ^d   Schmidt, Rebecca ^a   Zengerle, Anja ^a   Winter, Gerhard ^e   Eibl, Hansjörg ^f   Peller, Michael ^a   Reiser, Maximilian ^a   Issels, Rolf D ^a,b   Lindner, Lars H ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Max Planck Innovation GmbH   (Germany)

^d Coriolis PharmaService GmbH ^*  (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

Drug delivery; Hyperthermia; Phosphatidyloligoglycerol; Thermosensitive liposomes; Vesicle size

Indexed keywords

ANTICANCER DRUG; BI-LAYER; BIOPHYSICAL PROPERTIES; CARBOXYFLUORESCEIN; DOXORUBICIN; FLUORESCENT DYES; HYPERTHERMIA; IN-VITRO; IN-VIVO; MAGNETIC RESONANCE CONTRAST AGENTS; PHASE TRANSITION TEMPERATURES; PHOSPHATIDYLOLIGOGLYCEROL; POLYCARBONATE FILTERS; RELEASE PROPERTY; RELEASE RATE; SIDE EFFECT; SIGNAL INTENSITIES; SIZE DEPENDENCY; TEMPERATURE RANGE; THERMOSENSITIVE LIPOSOMES; VESICLE SIZE; WATER EXCHANGE;

CUSTOMER SATISFACTION; DRUG DELIVERY; LIPOSOMES; MAGNETIC RESONANCE; PHASE TRANSITIONS;

PHOSPHOLIPIDS;

1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHOGLYCEROGLYCEROL; CARBOXYFLUORESCEIN; DOXORUBICIN; GADODIAMIDE; GLYCEROL; LIPOSOME; POLYCARBONATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; HEAT SENSITIVITY; IN VIVO STUDY; PRIORITY JOURNAL; QUALITY CONTROL; TRANSITION TEMPERATURE; WATER PERMEABILITY;

ANTIBIOTICS, ANTINEOPLASTIC; CHEMISTRY, PHARMACEUTICAL; CONTRAST MEDIA; DOXORUBICIN; DRUG COMPOUNDING; FLUORESCEINS; FLUORESCENT DYES; GADOLINIUM DTPA; HUMANS; HYPERTHERMIA, INDUCED; KINETICS; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; NANOTECHNOLOGY; PARTICLE SIZE; PERMEABILITY; PHOSPHOLIPIDS; SOLUBILITY; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE;

EID: 78049472568     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.08.013     Document Type: Article

References (52)

1. Wagner V., Dullaart A., Bock A.-K., Zweck A. The emerging nanomedicine landscape. Nat. Biotechnol. 2006, 24:1211-1217.
2. Lindner L.H., Hossann M. Factors affecting drug release from liposomes. Curr. Opin. Drug Discov. Devel. 2010, 13:111-123.
3. Wust P., Hildebrandt B., Sreenivasa G., Rau B., Gellermann J., Riess H., Felix R., Schlag P.M. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002, 3:487-497.
4. Issels R.D., Lindner L.H., Verweij J., Wust P., Reichardt P., Schem B.-C., Abdel-Rahman S., Daugaard S., Salat C., Wendtner C.-M., Vujaskovic Z., Wessalowski R., Jauch K.-W., Dürr H.R., Ploner F., Baur-Melnyk A., Mansmann U., Hiddemann W., Blay J.-Y., Hohenberger P. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2010, 11:561-570.
5. Yatvin M.B., Weinstein J.N., Dennis W.H., Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 1978, 202:1290-1293.
6. Needham D., Anyarambhatla G., Kong G., Dewhirst M.W. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res. 2000, 60:1197-1201.
7. Lindner L.H., Eichhorn M.E., Eibl H., Teichert N., Schmitt-Sody M., Issels R.D., Dellian M. Novel temperature-sensitive liposomes with prolonged circulation time. Clin. Cancer Res. 2004, 10:2168-2178.
8. Li L., ten Hagen T.L.M., Schipper D., Wijnberg T.M., van Rhoon G.C., Eggermont A.M.M., Lindner L.H., Koning G.A. Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia. J. Control. Release 2010, 143:274-279.
9. Papahadjopoulos D., Jacobson K., Nir S., Isac T. Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. Biochim. Biophys. Acta 1973, 311:330-348.
10. Nagayasu A., Uchiyama K., Kiwada H. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv. Drug Deliv. Rev. 1999, 40:75-87.
11. Mayer L.D., Tai L.C., Ko D.S., Masin D., Ginsberg R.S., Cullis P.R., Bally M.B. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. 1989, 49:5922-5930.
12. Nagayasu A., Shimooka T., Kiwada H. Effect of vesicle size on in vivo release of daunorubicin from hydrogenated egg phosphatidylcholine-based liposomes into blood circulation. Biol. Pharm. Bull. 1995, 18:1020-1023.
13. Cui J., Li C., Guo W., Li Y., Wang C., Zhang L., Zhang L., Hao Y., Wang Y. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?. J. Control. Release 2007, 118:204-215.
14. Hossann M., Wiggenhorn M., Schwerdt A., Wachholz K., Teichert N., Eibl H., Issels R.D., Lindner L.H. In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes. Biochim. Biophys. Acta 2007, 1768:2491-2499.
15. Mills J.K., Needham D. Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition. Biochim. Biophys. Acta 2005, 1716:77-96.
16. Lindner L.H., Hossann M., Vogeser M., Teichert N., Wachholz K., Eibl H., Hiddemann W., Issels R.D. Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release. J. Control. Release 2008, 125:112-120.
17. Eibl H. Synthesis of glycerophospholipids. Chem. Phys. Lipids 1980, 26:405-429.
18. Kötting J., Berger M.R., Unger C., Eibl H. Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations. Cancer Chemother. Pharmacol. 1992, 30:105-112.
19. 1-shortening gadodiamide. Contrast Media Mol. Imaging 2008, 3:19-26.
20. Eibl H., Lands W.E. A new, sensitive determination of phosphate. Anal. Biochem. 1969, 30:51-57.
21. Komatsu H., Okada S. Increased permeability of phase-separated liposomal membranes with mixtures of ethanol-induced interdigitated and non-interdigitated structures. Biochim. Biophys. Acta 1995, 1237:169-175.
22. 1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions. Magn. Reson. Med. 1992, 23:275-286.
23. de Smet M., Langereis S., van den Bosch S., Grüll H. Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. J. Control. Release 2010, 143:120-127.
24. Grit M., Crommelin D.J. Chemical stability of liposomes: implications for their physical stability. Chem. Phys. Lipids 1993, 64:3-18.
25. Mayer L.D., Hope M.J., Cullis P.R. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim. Biophys. Acta 1986, 858:161-168.
26. Biltonen R.L., Lichtenberg D. The use of differential scanning calorimetry as a tool to characterize liposome preparations. Chem. Phys. Lipids 1993, 64:129-142.
27. Fossheim S.L., Fahlvik A.K., Klaveness J., Muller R.N. Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity. Magn. Reson. Imaging 1999, 17:83-89.
28. Xiang T.-X., Anderson B.D. Liposomal drug transport: a molecular perspective from molecular dynamics simulations in lipid bilayers. Adv. Drug Deliv. Rev. 2006, 58:1357-1378.
29. Nagle J.F., Scott H.L. Lateral compressibility of lipid mono- and bilayers. Theory of membrane permeability. Biochim. Biophys. Acta 1978, 513:236-243.
30. Hatzakis N.S., Bhatia V.K., Larsen J., Madsen K.L., Bolinger P.-Y., Kunding A.H., Castillo J., Gether U., Hedegård P., Stamou D. How curved membranes recruit amphipathic helices and protein anchoring motifs. Nat. Chem. Biol. 2009, 5:835-841.
31. van Meer G., Voelker D.R., Feigenson G.W. Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 2008, 9:112-124.
32. Cohen B.E., Bangham A.D. Diffusion of small non-electrolytes across liposome membranes. Nature 1972, 236:173-174.
33. Noble C.O., Guo Z., Hayes M.E., Marks J.D., Park J.W., Benz C.C., Kirpotin D.B., Drummond D.C. Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine. Cancer Chemother. Pharmacol. 2009, 64:741-751.
34. Hosokawa T., Sami M., Kato Y., Hayakawa E. Alteration in the temperature-dependent content release property of thermosensitive liposomes in plasma. Chem. Pharm. Bull. 2003, 51:1227-1232.
35. Cullis P.R., Hope M.J., Bally M.B., Madden T.D., Mayer L.D., Fenske D.B. Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles. Biochim. Biophys. Acta 1997, 1331:187-211.
36. Dos Santos N., Cox K.A., McKenzie C.A., van Baarda F., Gallagher R.C., Karlsson G., Edwards K., Mayer L.D., Allen C., Bally M.B. pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol. Biochim. Biophys. Acta 2004, 1661:47-60.
37. Mayer L.D., Tai L.C., Bally M.B., Mitilenes G.N., Ginsberg R.S., Cullis P.R. Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim. Biophys. Acta 1990, 1025:143-151.
38. Sandström M.C., Ickenstein L.M., Mayer L.D., Edwards K. Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomes. J. Control. Release 2005, 107:131-142.
39. Tieleman D.P., Bentz J. Molecular dynamics simulation of the evolution of hydrophobic defects in one monolayer of a phosphatidylcholine bilayer: relevance for membrane fusion mechanisms. Biophys. J. 2002, 83:1501-1510.
40. Ickenstein L.M., Sandström M.C., Mayer L.D., Edwards K. Effects of phospholipid hydrolysis on the aggregate structure in DPPC/DSPE-PEG2000 liposome preparations after gel to liquid crystalline phase transition. Biochim. Biophys. Acta 2006, 1758:171-180.
41. Sandström M.C., Johansson E., Edwards K. Structure of mixed micelles formed in PEG-lipid/lipid dispersions. Langmuir 2007, 23:4192-4198.
42. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 2001, 41:189-207.
43. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 2000, 65:271-284.
44. Seynhaeve A.L.B., Hoving S., Schipper D., Vermeulen C.E., de Wiel-Ambagtsheer G.a., van Tiel S.T., Eggermont A.M.M., ten Hagen T.L.M. Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response. Cancer Res. 2007, 67:9455-9462.
45. Harrington K.J., Mohammadtaghi S., Uster P.S., Glass D., Peters A.M., Vile R.G., Stewart J.S. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin. Cancer Res. 2001, 7:243-254.
46. Maeda N., Takeuchi Y., Takada M., Sadzuka Y., Namba Y., Oku N. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome. J. Control. Release 2004, 100:41-52.
47. Shmeeda H., Tzemach D., Mak L., Gabizon A. Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage. J. Control. Release 2009, 136:155-160.
48. Koning G.A., Eggermont A.M.M., Lindner L.H., ten Hagen T.L.M. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharm. Res. 2010, 27:1750-1754.
49. Lagendijk J.J., van Rhoon G.C., Hornsleth S.N., Wust P., de Leeuw A.C., Schneider C.J., van Dijk J.D., van der Zee J., van Heek-Romanowski R., Rahman S.A., Gromoll C. ESHO quality assurance guidelines for regional hyperthermia. Int. J. Hyperthermia 1998, 14:125-133.
50. Peller M., Schwerdt A., Hossann M., Reinl H.M., Wang T., Sourbron S., Ogris M., Lindner L.H. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors. Invest. Radiol. 2008, 43:877-892.
51. Viglianti B.L., Ponce A.M., Michelich C.R., Yu D., Abraham S.A., Sanders L., Yarmolenko P.S., Schroeder T., MacFall J.R., Barboriak D.P., Colvin O.M., Bally M.B., Dewhirst M.W. Chemodosimetry of in vivo tumor liposomal drug concentration using MRI. Magn. Reson. Med. 2006, 56:1011-1018.
52. 1 relaxivity of core-encapsulated gadolinium liposomal contrast agents - effect of liposome size and internal gadolinium concentration. Acad. Radiol. 2008, 15:1259-1263.